Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Operating Leases (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Operating Leases for 4 consecutive years, with $4.5 million as the latest value for Q4 2022.

  • Quarterly Operating Leases fell 64.75% to $4.5 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2022, down 64.75% year-over-year, with the annual reading at $8.1 million for FY2022, 36.7% down from the prior year.
  • Operating Leases for Q4 2022 was $4.5 million at NovaBridge Biosciences, down from $12.8 million in the prior quarter.
  • The five-year high for Operating Leases was $12.8 million in Q4 2021, with the low at $836250.7 in Q4 2020.
  • Average Operating Leases over 4 years is $4.8 million, with a median of $2.8 million recorded in 2019.
  • The sharpest move saw Operating Leases soared 1429.7% in 2021, then plummeted 64.75% in 2022.
  • Over 4 years, Operating Leases stood at $1.1 million in 2019, then dropped by 21.33% to $836250.7 in 2020, then skyrocketed by 1429.7% to $12.8 million in 2021, then tumbled by 64.75% to $4.5 million in 2022.
  • According to Business Quant data, Operating Leases over the past three periods came in at $4.5 million, $12.8 million, and $836250.7 for Q4 2022, Q4 2021, and Q4 2020 respectively.